Clinical Newsletter

Clinical Newsletter

Regular updates on our latest clinical studies.

Subscribe

Publication search

Our research and development teams operate at a global level and generate synergies from our collective expertise and by drawing on related disciplines. We are also constantly exchanging information at an international level with independent technical institutions, key opinion leaders and multipliers in order to be able to ensure cooperation and knowledge management of the highest order. As part of this process, we also conduct extensive research, the results of which we continually present in workshops, at conferences and symposiums - either in documentation or talks given by our cooperation partners - and also publish in renowned scientific journals. This database contains a large number of these evidence-based scientific articles, most of which have been evaluated by independent assessors:

  1. Poster

    OFFLOADING ALLOWING FOR MOBILIZATION IN POST-SURGICAL REHABILITATION OF DIABETIC FOOT ULCER PATIENTS

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  2. Poster

    TREATMENT WITH A COLLAGEN DRESSING OF TWO PATIENTS WITH STAGNATING SKIN LESIONS CAUSED BY IRRADIATION THERAPY

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  3. Poster

    A NEW TREATMENT OF THE “OPEN ABDOMEN” WITH CONTROLLED NEGATIVE PRESSURE** AND A NEW DEVICE*

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  4. Poster

    A national survey of the nursing practice in the treatment of hyperkeratosis associated with venous hypertension.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  5. Poster

    IS POLIHEXANIDE A NEW EFFECTIVE TREATMENT FOR INFECTED WOUNDS FOR FRANCOPHONE COUNTRIES?

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Further languages
  6. Poster

    COMBINATION OF NEGATIVE PRESSURE WOUND THERAPY (NPWT)* WITH A COLLAGEN DRESSING** TO PROMOTE CLOSURE OF WOUND CAVITIES AND GRANULATION

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  7. Poster

    The challenges of implementing new treatment regimes in a hospital setting.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
  8. Poster

    Treatment of a painful ulcer with an ionic sheet hydrogel dressing.

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Products Suprasorb X
    Further versions
  9. Poster

    THE CARE OF PATIENTS WITH STAGNATING DIABETIC FOOT ULCERS USING A COLLAGEN DRESSING

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium
    Products Suprasorb P
    Downloads Citation (RIS)
  10. Poster

    THE WOUND DEBRIDER –A NEW MONOFILAMENT FIBRE TECHNOLOGY: Results of a pilot study

    Poster presented at EWMA 2011 25.05.2011 Brussels, Belgium

    Introduction:

    Debridement is a basic necessity to induce the process of tissue repair especially in chronic wounds.

     

    Methods:

    In this prospective, blindly assessed pilot study we used a new debrider technology with specific monofilament fibres in a unique texture to evaluate its efficacy, safety and tolerability. In altogether 11 patients exhibiting all kinds of wound-associated debris (biofilms, slough, necrotic crusts, ‘hyperkeratotic’ plaques, see table 1) the debrider*, wetted with physiological solution, was wiped without specific force over the wound for about 2-4 minutes.

     

    Results:

    The debrider* removed almost all debris leaving healthy granulation tissue (including even small epithelialised islands of vital tissues) intact. (fig. 1 - 4) The patients didn’t feel adverse symptoms, in particular no pain. The healthcare professional’s global assessment revealed that the use of the debrider* was easy, fast and very efficient. Scanning electron microscopic analyses identified the majority of the removed debris tightly packed within the monofilament texture (fig. 5 and 6). Finally, a surgeon blindly assessed pictures of wounds (taken before / after the debridement), ranked all debridement results into the best category and one wound formerly classified for a need of surgical debridement as “equal to surgical debridement”.

     

    Conclusion:

    We have generated the basic proof of concept that the new debrider*-based technology is easy, fast, highly efficient, safe and well-tolerated. Further, since the new debrider* allows its broad use not only by specialised physicians but also by all healthcare professionals, it is anticipated that its use would save substantial costs. Hence, the new debrider* puts the need of other wound bed preparation procedures into question.

    Products Debrisoft Pad
    Further versions